HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DUALITYBIO-B

335.000

-13.800-3.96%

Volume:375.46K

Turnover:127.29M

Market Cap:30.20B

PE:-2.55

High:350.400

Open:350.400

Low:334.000

Close:348.800

52wk High:563.500

52wk Low:165.500

Shares:90.14M

HK Float Shares:90.14M

Volume Ratio:2.62

T/O Rate:0.42%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-131.304

ROE:--

ROA:-6.51%

PB:9.13

PE(LYR):-2.55

PS:12.26

Loading ...

Overview Company News Filings

Duality Biotherapeutics Says DB-1311 Shows Signs of Activity in Early-Stage Prostate Cancer Study

MT Newswires Live

Duality Biotherapeutics, Inc. (9606) Presents DB-1311/BNT324 Study Updates at ASCO GU Cancers Symposium 2026

Bulletin Express

DUALITYBIO-B Announces Phase 1/2 Trial Results for DB-1311/BNT324 at 2026 ASCO GU Symposium

Duality Biotherapeutics to Present Updated DB-1311/BNT324 Phase 1/2 mCRPC Data at ASCO GU 2026

Hong Kong Stock Market Movement | DUALITYBIO-B (09606) Surges Over 6%, Company's 2026 Clinical Data Expected for Dense Readout

Hong Kong Stock Movement | DUALITYBIO-B (09606) Rises Over 4% in Morning Session as ADAM9-Targeting ADC Cancer Drug Approved for Clinical Trials in China

Duality Biotherapeutics Executive Director of Human Resources & Executive Director Wen Si Sells 100% Of Holding

Simply Wall St.

Hong Kong Stock Movement | DUALITYBIO-B (09606) Surges Over 12% on Rich 2026 Catalysts; Institution Raises Target Price

GTHT Raises DUALITYBIO-B (09606) Target Price to HK$455.56, Maintains Add Rating

Duality Biotherapeutics Inc. held extraordinary general meeting

Hong Kong Stocks Movement | DUALITYBIO-B (09606) Rises Over 3% in Early Trading as DB-1310 Receives FDA Fast Track Designation

DUALITYBIO-B (09606) Proposes Adoption of 2025 Share Scheme

Duality Biotherapeutics Inc. Proposes 2025 Share Scheme for Shareholder Approval at Upcoming EGM

HK Stock Connect Shareholding Changes | December 8

HK Movers | Biotech Stocks Rise. Ascletis up 9%; Antengene up over 5%; Remegen, Laekna, Akeso, Hua Medicine up About 4%

Tiger Newspress

HK Movers | Biotech Stocks Fall. Ascletis-B down 11%; Hua Medicine-B, Mabpharm-B down about 7%; Antengene-B down 5%; Ascentage-B down 4%.

Tiger Newspress

Are Investors Undervaluing Duality Biotherapeutics, Inc. (HKG:9606) By 49%?

Simply Wall St.

Southbound Capital Flow Data (T+2) for Dec 2

CISI FIN Initiates Coverage on DUALITYBIO-B (09606) with "Overweight" Rating, Highlights Leadership in Next-Gen ADC Innovation

HK Pharma Shares Gained. CSPC Pharma Up 7%; 3SBio Up 6%; Remegen Up 4%; Sino Biopharm, Junshi Bio And Hengrui Pharma Up 3%

Tiger Newspress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/09606/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"DUALITYBIO-B","latestPrice":335,"timestamp":1771910939483,"preClose":348.8,"halted":0,"volume":375464,"delay":0,"changeRate":-0.03956422018348627,"floatShares":90137700,"shares":90137700,"eps":-131.30424,"marketStatus":"Trading","change":-13.8,"latestTime":"02-24 13:29:04","open":350.4,"high":350.4,"low":334,"amount":127292370,"amplitude":0.047018,"askPrice":335.4,"askSize":1300,"bidPrice":335,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-34.438,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771920600000},"marketStatusCode":2,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":348.8,"openAndCloseTimeList":[[1771896600000,1771905600000],[1771909200000,1771920000000]],"volumeRatio":2.624798,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","floatShares":90137700,"roa":"-6.51%","roe":"--","lyrEps":-131.30425,"volumeRatio":2.624798,"shares":90137700,"dividePrice":0,"high":350.4,"amplitude":0.047018,"preClose":348.8,"low":334,"week52Low":165.5,"pbRate":"9.13","psRate":"12.26","week52High":563.5,"institutionHeld":0,"latestPrice":335,"committee":-0.130435,"eps":-131.30424,"divideRate":0,"volume":375464,"delay":0,"ttmEps":-34.438,"open":350.4,"prevYearClose":298.2,"prevWeekClose":349,"prevMonthClose":329.8,"prevQuarterClose":298.2,"fiveDayClose":327,"twentyDayClose":322,"sixtyDayClose":325.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09606\",params:#limit:5,,,undefined,":[{"date":"2025-08-26","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09606\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09606\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.7143,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":7,"updateTime":1761321600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09606\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09606","date":"2026-02-23","current":-9.768279,"percent":0.587678,"low":-29.984477,"twenty":-20.540923,"median":-10.392201,"eighty":-9.10067,"high":-7.368305,"avg":-14.343766,"sd":6.343786,"marketCap":31440034643},"quantilePoints":[{"date":"2025-04-17","current":-14.905978,"twenty":-15.065639,"median":-14.442293,"eighty":-11.334487,"marketCap":16635152800},{"date":"2025-04-25","current":-15.846935,"twenty":-16.770434,"median":-15.576033,"eighty":-14.349556,"marketCap":17719522633},{"date":"2025-05-02","current":-16.438538,"twenty":-16.715855,"median":-16.124153,"eighty":-14.985809,"marketCap":18420101638},{"date":"2025-05-09","current":-15.074661,"twenty":-16.551291,"median":-15.826729,"eighty":-15.074661,"marketCap":17010399982},{"date":"2025-05-16","current":-15.043786,"twenty":-16.438538,"median":-15.220044,"eighty":-14.405796,"marketCap":17114249721},{"date":"2025-05-23","current":-16.495727,"twenty":-16.438538,"median":-15.262587,"eighty":-14.582474,"marketCap":18822153243},{"date":"2025-05-30","current":-16.208434,"twenty":-16.401371,"median":-15.460562,"eighty":-14.726132,"marketCap":18575651704},{"date":"2025-06-06","current":-16.427701,"twenty":-16.438538,"median":-15.666395,"eighty":-14.905978,"marketCap":18874975001},{"date":"2025-06-13","current":-20.940103,"twenty":-16.693343,"median":-15.893657,"eighty":-15.005253,"marketCap":24069114577},{"date":"2025-06-20","current":-18.479443,"twenty":-18.428819,"median":-16.104695,"eighty":-15.043786,"marketCap":21199132371},{"date":"2025-06-27","current":-18.0452,"twenty":-18.863356,"median":-16.282988,"eighty":-15.074661,"marketCap":20758951051},{"date":"2025-07-04","current":-21.227749,"twenty":-18.942282,"median":-16.427701,"eighty":-15.074735,"marketCap":24421259633},{"date":"2025-07-11","current":-22.045806,"twenty":-19.683704,"median":-16.508309,"eighty":-15.190609,"marketCap":25336836779},{"date":"2025-07-18","current":-25.758166,"twenty":-20.839221,"median":-16.693343,"eighty":-15.21995,"marketCap":29580184704},{"date":"2025-07-25","current":-25.970367,"twenty":-21.539184,"median":-16.981252,"eighty":-15.260218,"marketCap":29932329760},{"date":"2025-08-01","current":-24.963588,"twenty":-22.267132,"median":-18.096065,"eighty":-15.298157,"marketCap":28594178547},{"date":"2025-08-08","current":-27.998627,"twenty":-24.402884,"median":-18.454131,"eighty":-15.429476,"marketCap":32150843612},{"date":"2025-08-15","current":-27.487815,"twenty":-25.397092,"median":-18.863356,"eighty":-15.513126,"marketCap":31516982512},{"date":"2025-08-22","current":-26.341915,"twenty":-25.761111,"median":-19.052333,"eighty":-15.750472,"marketCap":30108402288},{"date":"2025-08-29","current":-8.977182,"twenty":-25.761111,"median":-19.118727,"eighty":-15.513126,"marketCap":27784244918},{"date":"2025-09-05","current":-10.341403,"twenty":-25.547361,"median":-18.897362,"eighty":-15.21995,"marketCap":31974771084},{"date":"2025-09-12","current":-12.806892,"twenty":-25.484142,"median":-18.479443,"eighty":-15.036079,"marketCap":39669140558},{"date":"2025-09-19","current":-11.291493,"twenty":-25.397092,"median":-18.151913,"eighty":-14.569138,"marketCap":34950396808},{"date":"2025-09-26","current":-9.575685,"twenty":-25.265241,"median":-17.183112,"eighty":-14.242848,"marketCap":29562577451},{"date":"2025-10-03","current":-9.769092,"twenty":-25.225948,"median":-16.756996,"eighty":-13.467837,"marketCap":30231653057},{"date":"2025-10-10","current":-8.39875,"twenty":-25.201143,"median":-16.551291,"eighty":-12.508489,"marketCap":25953090627},{"date":"2025-10-17","current":-9.52866,"twenty":-25.090759,"median":-16.467132,"eighty":-11.127698,"marketCap":29421719428},{"date":"2025-10-24","current":-8.24833,"twenty":-24.683236,"median":-16.401371,"eighty":-10.383008,"marketCap":25477694801},{"date":"2025-10-31","current":-8.936138,"twenty":-24.228898,"median":-16.208434,"eighty":-10.01166,"marketCap":27643386896},{"date":"2025-11-07","current":-8.115895,"twenty":-24.0933,"median":-15.983588,"eighty":-9.661913,"marketCap":25090335240},{"date":"2025-11-14","current":-9.615008,"twenty":-24.036348,"median":-15.846935,"eighty":-9.533336,"marketCap":29809078990},{"date":"2025-11-21","current":-8.88084,"twenty":-23.659864,"median":-15.493415,"eighty":-9.411746,"marketCap":27520136126},{"date":"2025-11-28","current":-9.805814,"twenty":-23.032171,"median":-15.270261,"eighty":-9.358381,"marketCap":30496838785},{"date":"2025-12-05","current":-9.522579,"twenty":-22.810207,"median":-15.147164,"eighty":-9.358381,"marketCap":29666872704},{"date":"2025-12-12","current":-9.227769,"twenty":-22.078047,"median":-15.043786,"eighty":-9.232281,"marketCap":28801588916},{"date":"2025-12-19","current":-9.562517,"twenty":-22.024358,"median":-14.816055,"eighty":-9.195431,"marketCap":29916743432},{"date":"2025-12-24","current":-8.86445,"twenty":-21.960012,"median":-14.582474,"eighty":-9.185632,"marketCap":27819193982},{"date":"2026-01-02","current":-8.361415,"twenty":-21.780535,"median":-14.405796,"eighty":-9.071858,"marketCap":26343799029},{"date":"2026-01-09","current":-10.158481,"twenty":-21.573184,"median":-14.143758,"eighty":-9.138635,"marketCap":32085396254},{"date":"2026-01-16","current":-10.130227,"twenty":-21.338723,"median":-13.671075,"eighty":-9.159542,"marketCap":32100133626},{"date":"2026-01-23","current":-9.450777,"twenty":-21.128733,"median":-12.833558,"eighty":-9.159542,"marketCap":29918397524},{"date":"2026-01-30","current":-9.27281,"twenty":-20.989151,"median":-11.556174,"eighty":-9.159542,"marketCap":29489203537},{"date":"2026-02-06","current":-8.834279,"twenty":-20.864442,"median":-11.154997,"eighty":-9.026205,"marketCap":28165855410},{"date":"2026-02-13","current":-9.445101,"twenty":-20.730279,"median":-10.443288,"eighty":-9.076015,"marketCap":30286271904},{"date":"2026-02-20","current":-9.824687,"twenty":-20.674464,"median":-10.43817,"eighty":-9.09489,"marketCap":31458062186},{"date":"2026-02-23","current":-9.811642,"twenty":-20.540923,"median":-10.392201,"eighty":-9.10067,"marketCap":31440034643}],"updateTime":1771904434133},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09606\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2613763897","title":"Duality Biotherapeutics Says DB-1311 Shows Signs of Activity in Early-Stage Prostate Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2613763897","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613763897?lang=en_us&edition=fundamental","pubTime":"2026-02-24 11:33","pubTimestamp":1771904032,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics (HKG:9606) said updated data from an early-stage study of DB-1311/BNT324 showed signs of activity in patients with advanced prostate cancer who had already received multiple pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HK0000500386.USD","BK1161","HK0000252160.HKD","SSI","LU2543165471.USD","BK4585","HK0000252152.HKD","BK4588","DB","BK4566","BK4118","09606","BK4552"],"gpt_icon":0},{"id":"1140530522","title":"Duality Biotherapeutics, Inc. (9606) Presents DB-1311/BNT324 Study Updates at ASCO GU Cancers Symposium 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1140530522","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140530522?lang=en_us&edition=fundamental","pubTime":"2026-02-24 06:23","pubTimestamp":1771885417,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics, Inc. (the “Company”) (Stock Code: 9606) announced updated results from a Phase 1/2 DB-1311-O-1001 study (NCT05914116) of DB-1311/BNT324, an investigational B7H3 antibody drug...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"gpt_icon":0},{"id":"1101379908","title":"DUALITYBIO-B Announces Phase 1/2 Trial Results for DB-1311/BNT324 at 2026 ASCO GU Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=1101379908","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101379908?lang=en_us&edition=fundamental","pubTime":"2026-02-24 06:10","pubTimestamp":1771884635,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) has announced that updated efficacy and safety results from the Phase 1/2 DB-1311-O-1001 study (NCT05914116) for its investigational B7H3 antibody-drug conjugate (ADC),...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","BK4588","DB","HK0000500386.USD","09606","LU2543165471.USD","BK4566","BK4118","BK4552","BK1161","HK0000252160.HKD","BK4585"],"gpt_icon":0},{"id":"2613275840","title":"Duality Biotherapeutics to Present Updated DB-1311/BNT324 Phase 1/2 mCRPC Data at ASCO GU 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2613275840","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613275840?lang=en_us&edition=fundamental","pubTime":"2026-02-24 06:03","pubTimestamp":1771884238,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics Inc. announced updated efficacy and safety results from its Phase 1/2 DB-1311-O-1001 study  evaluating DB-1311/BNT324, an investigational B7-H3 antibody-drug conjugate, in heavily pretreated metastatic castration-resistant prostate cancer. The company said the data will be presented at the ASCO Genitourinary Cancers Symposium 2026  and that the study abstract was published on the symposium website on February 23, 2026. As of the September 5, 2025 data cutoff, 104 patients had been treated; among 58 response-evaluable patients, confirmed objective response rate was 34.5% and disease control rate was 87.9%, with median radiographic progression-free survival of 11.3 months in 82 evaluable patients; outcomes were reported as similar in patients with and without prior lutetium-177 PSMA-617 treatment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL32V5N0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","HK0000252152.HKD","09606","HK0000252160.HKD","HK0000500386.USD","BK1161"],"gpt_icon":0},{"id":"1118688603","title":"Hong Kong Stock Market Movement | DUALITYBIO-B (09606) Surges Over 6%, Company's 2026 Clinical Data Expected for Dense Readout","url":"https://stock-news.laohu8.com/highlight/detail?id=1118688603","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118688603?lang=en_us&edition=fundamental","pubTime":"2026-01-27 14:30","pubTimestamp":1769495422,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) rose more than 6%. As of the time of writing, the stock was up 6.04%, trading at HKD 340.6, with a turnover of HKD 154 million. On the news front, according to Pharmaceutical...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","BK1161","HK0000500386.USD","09606","LU2543165471.USD","HK0000252152.HKD"],"gpt_icon":0},{"id":"1138834224","title":"Hong Kong Stock Movement | DUALITYBIO-B (09606) Rises Over 4% in Morning Session as ADAM9-Targeting ADC Cancer Drug Approved for Clinical Trials in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1138834224","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138834224?lang=en_us&edition=fundamental","pubTime":"2026-01-20 09:53","pubTimestamp":1768873996,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) saw its shares rise more than 4% during the morning trading session. At the time of writing, the stock was up 2.42%, trading at HKD 363.6, with a turnover of HKD 51.06 million....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","BK4080","HK0000252160.HKD","LU2543165471.USD","HK0000500386.USD","ADC","HK0000252152.HKD","BK1161","09606"],"gpt_icon":0},{"id":"2604159280","title":"Duality Biotherapeutics Executive Director of Human Resources & Executive Director Wen Si Sells 100% Of Holding","url":"https://stock-news.laohu8.com/highlight/detail?id=2604159280","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604159280?lang=en_us&edition=fundamental","pubTime":"2026-01-20 07:07","pubTimestamp":1768864035,"startTime":"0","endTime":"0","summary":"Some Duality Biotherapeutics, Inc. ( HKG:9606 ) shareholders may be a little concerned to see that the Executive...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9606/duality-biotherapeutics-shares/news/duality-biotherapeutics-executive-director-of-human-resource","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9606/duality-biotherapeutics-shares/news/duality-biotherapeutics-executive-director-of-human-resource","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HK0000500386.USD","LU2543165471.USD","09606","HK0000252160.HKD","BK1161","HK0000252152.HKD"],"gpt_icon":0},{"id":"1107238891","title":"Hong Kong Stock Movement | DUALITYBIO-B (09606) Surges Over 12% on Rich 2026 Catalysts; Institution Raises Target Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1107238891","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107238891?lang=en_us&edition=fundamental","pubTime":"2026-01-05 15:08","pubTimestamp":1767596885,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) surged more than 12%. As of writing, the stock was up 12.08% to HK$332.2, with a turnover of HK$321 million. On the news front, Guotai Haitong Securities noted that, based on a...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000500386.USD","BK1161","HK0000252152.HKD","09606","LU2543165471.USD","HK0000252160.HKD"],"gpt_icon":0},{"id":"1162404111","title":"GTHT Raises DUALITYBIO-B (09606) Target Price to HK$455.56, Maintains Add Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1162404111","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162404111?lang=en_us&edition=fundamental","pubTime":"2026-01-05 09:26","pubTimestamp":1767576398,"startTime":"0","endTime":"0","summary":"GTHT has released a research report stating that, based on the exceptionally smooth progress of DUALITYBIO-B's (09606) pipeline in 2025, it has raised the potential global peak sales expectations for...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000500386.USD","BK1564","BK1161","HK0000252160.HKD","BK1147","HK0000252152.HKD","LU2543165471.USD","02611","09606"],"gpt_icon":0},{"id":"2595796720","title":"Duality Biotherapeutics Inc. held extraordinary general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2595796720","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595796720?lang=en_us&edition=fundamental","pubTime":"2025-12-30 18:42","pubTimestamp":1767091326,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics Inc. held an extraordinary general meeting on December 30, 2025. All proposals set out in the meeting notice were approved by shareholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Duality Biotherapeutics Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 30, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDL5h8ph5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","HK0000252160.HKD","LU2543165471.USD","HK0000500386.USD","BK1161","09606"],"gpt_icon":0},{"id":"1189000187","title":"Hong Kong Stocks Movement | DUALITYBIO-B (09606) Rises Over 3% in Early Trading as DB-1310 Receives FDA Fast Track Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=1189000187","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189000187?lang=en_us&edition=fundamental","pubTime":"2025-12-19 09:52","pubTimestamp":1766109155,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) surged over 3% in early trading, reaching HK$318 with a turnover of HK$23.3955 million. The company announced that the U.S. Food and Drug Administration (FDA) has granted Fast...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4552","BK4118","LU2543165471.USD","HK0000500386.USD","09606","HK0000252152.HKD","HK0000252160.HKD","BK4566","BK4585","DB","BK4588"],"gpt_icon":0},{"id":"1118661640","title":"DUALITYBIO-B (09606) Proposes Adoption of 2025 Share Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1118661640","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118661640?lang=en_us&edition=fundamental","pubTime":"2025-12-14 18:16","pubTimestamp":1765707370,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) announced that on December 13, 2025, its board of directors resolved to propose the adoption of the 2025 Share Scheme, subject to approval by shareholders. The 2025 Share Scheme...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","LU2543165471.USD","09606","HK0000252160.HKD","BK1161","HK0000500386.USD"],"gpt_icon":0},{"id":"2591681666","title":"Duality Biotherapeutics Inc. Proposes 2025 Share Scheme for Shareholder Approval at Upcoming EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2591681666","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591681666?lang=en_us&edition=fundamental","pubTime":"2025-12-14 18:06","pubTimestamp":1765706815,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics Inc. has announced a proposal for the adoption of the 2025 Share Scheme, which aims to attract, retain, and reward participants who contribute to the company's long-term growth and success. Shareholders will vote on this proposal at the upcoming extraordinary general meeting. The board recommends voting in favor of the adoption of the 2025 Share Scheme.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Duality Biotherapeutics Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251214:nNDL1nVPrZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","HK0000500386.USD","HK0000252160.HKD","LU2543165471.USD","BK1161","09606"],"gpt_icon":0},{"id":"1173595696","title":"HK Stock Connect Shareholding Changes | December 8","url":"https://stock-news.laohu8.com/highlight/detail?id=1173595696","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173595696?lang=en_us&edition=fundamental","pubTime":"2025-12-08 08:38","pubTimestamp":1765154326,"startTime":"0","endTime":"0","summary":"According to data disclosed on December 5, 2025, the top gainers in HK Stock Connect shareholding ratios were Southern Hong Kong US Tech (03442), Synagistics Holdings (02562), and Jihong Co (02603),...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01138","02582","BK1507","BK1237","BK1506","02013","HK0000500386.USD","02600","06869","BK1110","BK1219","BK1109","06680","02202","02631","02550","BK1607","BK1594","03678","03759","BK1258","BK1197","06865","BK1225","BK1514","BK1240","01385","BK1229","BK1589","BK1592","09885","00568","03958","00694","02208","BK1583","00763","09606","BK1096","LU2148510915.USD","01858","09863","BK1561","000002","IE0034224299.USD","01958","03442","BK1539","BK1526","BK1558","02465","02603","BK1504","BK1597","01709","BK1138","02562","82333","BK1119","02498","BK1169","BK1585","BK1196","BK1183","BK1163","BK1529","02587","06166","LU2488822045.USD","BK1214","02228","06683","01341","03069","01317","02828","BK1137","BK1149","BK1535","GWLLY","02402","BK1513","BK1596","00347","BK1141","HK0000252152.HKD","BK1516","02367","BK1523","01282","02238","BK1613","00638","BK1161","MCHmain","BK1610","09858","LU0307460666.USD","03347","LU1064130708.USD","01233","BK1511","03319","BK1555","02800","BK1100","00187","01478","06682","BK1175","HK0000252160.HKD","BK1228","BK1617","BK1205","BK1212","BK1568","03441","BK1587","BK1554","BK1556","BK1179","BK1202","02333","601633","LU0588546209.SGD","LU2543165471.USD","02648","BK1521","BK1147","BK1542","BK1171","BK1116","BK1518","BK1207","02050","BK1590","SG9999006597.SGD","BK1166","BK1564","BK1576","BK1505","SG9999004311.SGD","LU1064131003.USD","BK1546","BK1614","SG9999014674.SGD"],"gpt_icon":1},{"id":"1127489049","title":"HK Movers | Biotech Stocks Rise. Ascletis up 9%; Antengene up over 5%; Remegen, Laekna, Akeso, Hua Medicine up About 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1127489049","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127489049?lang=en_us&edition=fundamental","pubTime":"2025-12-04 10:26","pubTimestamp":1764815206,"startTime":"0","endTime":"0","summary":"Biotech stocks jumped in Hong Kong. Ascletis up 9%; Antengene up over 5%; Remegen, Laekna, Akeso, Hua Medicine up about 4%; Zai Lab up over 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"2c8d9a47d2e27ece6292940208c30d20","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","03347","09966","06978","02269","02137","09688","02268","06606","03759","09995","02359","01672"],"gpt_icon":0},{"id":"1109808809","title":"HK Movers | Biotech Stocks Fall. Ascletis-B down 11%; Hua Medicine-B, Mabpharm-B down about 7%; Antengene-B down 5%; Ascentage-B down 4%.","url":"https://stock-news.laohu8.com/highlight/detail?id=1109808809","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109808809?lang=en_us&edition=fundamental","pubTime":"2025-12-03 13:18","pubTimestamp":1764739138,"startTime":"0","endTime":"0","summary":"Bitech stocks fell in Hong Kong. Ascletis-B down 11%; Hua Medicine-B, Mabpharm-B down about 7%; Antengene-B down 5%; Ascentage-B down 4%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"2c8d9a47d2e27ece6292940208c30d20","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347","03759","06606","09606","02359","02269","09688","09966","01672","02137","06978","09995","02268"],"gpt_icon":0},{"id":"2588058510","title":"Are Investors Undervaluing Duality Biotherapeutics, Inc. (HKG:9606) By 49%?","url":"https://stock-news.laohu8.com/highlight/detail?id=2588058510","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588058510?lang=en_us&edition=fundamental","pubTime":"2025-12-02 15:58","pubTimestamp":1764662323,"startTime":"0","endTime":"0","summary":"Key Insights Duality Biotherapeutics' estimated fair value is HK$664 based on 2 Stage Free Cash Flow to Equity Duality...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9606/duality-biotherapeutics-shares/news/are-investors-undervaluing-duality-biotherapeutics-inc-hkg96","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9606/duality-biotherapeutics-shares/news/are-investors-undervaluing-duality-biotherapeutics-inc-hkg96","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HK0000252152.HKD","FCF","HK0000500386.USD","TV","DCF","ISBC","BK4100","HK0000252160.HKD","LU2543165471.USD","BK4211","BK1161","09606"],"gpt_icon":0},{"id":"1157668357","title":"Southbound Capital Flow Data (T+2) for Dec 2","url":"https://stock-news.laohu8.com/highlight/detail?id=1157668357","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157668357?lang=en_us&edition=fundamental","pubTime":"2025-12-02 07:32","pubTimestamp":1764631967,"startTime":"0","endTime":"0","summary":"On November 27, Alibaba-W (09988), Pop Mart (09992), and China Merchants Bank (03968) topped the market in terms of net southbound capital inflows, recording inflows of HK$911 million, HK$442...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0197773160.USD","LU1008478684.HKD","LU1568876335.HKD","03877","SG9999003461.SGD","IE00BQXX3C00.GBP","LU1224709979.USD","SGXZ90724238.SGD","LU0169518387.USD","BK1594","LU1282651121.HKD","LU1785774172.SGD","LU1282649067.USD","LU0540923850.HKD","LU2237443978.SGD","LU1634259391.SGD","HMTD.SI","LU0320764599.SGD","LU2449936058.SGD","LU0985320562.USD","BK1604","SG9999015952.SGD","LU1282649141.HKD","LU1211504680.USD","LU1568876251.USD","LU0127658192.USD","LU0210526637.USD","LU0359201885.HKD","BK1185","00762","LU0235996351.USD","LU0543330566.HKD","LU1226288253.USD","BK1184","LU0577902611.USD","LU0972618739.USD","LU0531970944.HKD","LU0054450605.USD","IE0009570106.USD","LU0516423174.USD","00598","LU1734074674.USD","LU0651947912.USD","BK1588","LU2242644610.SGD","LU2048586759.USD","LU1993786604.SGD","LU0329678337.USD","BK1507","LU1720051108.HKD","LU0054237671.USD","LU1051769294.HKD","LU0244354667.USD","LU0251144936.SGD","BK1560","BK1133","LU0577902298.EUR","LU1794554557.SGD","LU1831875114.USD","BK1516","LU0762540952.USD","LU1282651048.USD","81024","LU0541501648.USD","SGXZ81514606.USD","LU1675838814.USD","LU0348735423.USD","XIACY","LU0188438112.USD","LU0541502299.USD","LU0048388663.USD","LU2362541513.USD","IE0008368411.USD","IE00BVYPNQ40.USD","LU0326950275.SGD","LU0588545904.SGD","03347","LU0823040885.USD","HK0000320264.USD","LU0633140727.USD","LU0231483743.USD","LU1201861165.SGD","IE00B031J352.USD","IE00BMPRXN33.USD","LU0173614495.USD","00081","BK1590","LU0320764755.SGD","BK1616","LU1328277881.USD","LU0831093199.SGD","IE00B0169L03.USD","LU0880133367.SGD","BK1584","LU0456846285.SGD","LU0630378429.USD","IE00BGHQDM52.EUR","LU0417516738.SGD","HXXD.SI","LU0886674414.USD","BK1249","00941","LU0738912210.USD","HK0000306685.HKD","HK0000320223.HKD","LU1051768304.USD","SG9999015986.USD","BK1137","LU0572940350.SGD","LU2237443549.SGD","06198","LU0791590937.USD","LU1719994722.HKD","LU2317271919.USD","LU0516422366.SGD","LU1226287529.USD","LU0918141887.USD","LU0708995153.HKD","LU0456854461.SGD","LU1634259557.SGD","LU0348783233.USD","LU2362541273.HKD","IE00BPRC5H50.USD","LU0359201612.USD","LU0328353924.USD","LU1046422090.SGD","BK1198","02888","LU1655091616.SGD","LU0043850808.USD","03441","SG9999001846.SGD","LU0314109678.HKD","LU1366334578.USD","SG9999001226.SGD","LU0979878070.USD","BK1242","LU0070217475.USD","IE00BMCWC346.EUR","LU1303224171.USD","LU0128522157.USD","LU0531971595.HKD","LU1226288097.SGD","SGXZ86797644.SGD","LU1328615791.USD","IE00B29SXG58.USD","LU0878005551.USD","LU1804176565.USD","LU0164880469.USD","LU0797268264.HKD","LU0084288322.USD","SG9999001069.SGD","SG9999012736.USD","IE0003851619.USD","LU0823426480.USD","IE00B031HW06.USD","LU0067412154.USD","BK1610","IE00BQXX3D17.EUR","LU0572944931.SGD","LU1152091168.USD","02899","BK1523","BK1173","00777","LU0594300419.USD","LU0819123356.HKD","LU0449515922.USD","LU1224444064.USD","LU1316542783.SGD","LU2265009873.SGD","LU1242518857.USD","LU0608807433.USD","LU2051468812.USD","LU0072913022.USD","LU0106252389.USD","LU1497734951.SGD","BK1607","SG9999001093.SGD","LU0882747503.HKD","LU0348784397.USD","LU1152091754.HKD","LU1497733557.USD","BK1618","BK1512","BK1502","BK1521","SG9999017495.SGD","BK1500","LU0784639295.USD","BK1517","LU0455707207.USD","03033","BK1193","LU1044876610.USD","LU0359202008.SGD","LU2226246903.HKD","LU0269904917.USD","LU1064131003.USD","LU0449509016.USD","LU2362540622.SGD","09880","LU0345769631.USD","LU1105468828.SGD","LU0165289439.USD","LU0823397103.USD","LU0229945570.USD","LU1981816686.USD","LU2125910500.SGD","SG9999014906.USD","IE0008369823.USD","LU0315179316.USD","LU0345780281.USD","LU1808992512.USD","LU2177674079.SGD","BK1163","SG9999001051.SGD","LU1515016050.SGD","LU0049853897.USD","LU0348825331.USD","BK1183","01186","LU0049112450.USD","LU0051755006.USD","LU0107464264.USD","LU0488056044.USD","LU1960683339.HKD","LU1226287875.USD","LU2462611646.USD","BK1135","BK1557","IE00B5MMRT66.SGD","BK1531","81810","01024","LU2498475776.HKD","IE00B0JY6N72.USD","LU0181495838.USD","LU0052750758.USD","IE00BGV7N243.SGD","BK1619","03968","LU1814569148.SGD","00700","MPNGY","SG9999006597.SGD","LU0648000940.SGD","IE00B8L5B284.USD","LU0348767384.USD","IE0003895053.USD","BK1519","IE00BMPRXR70.SGD","LU1119993845.HKD","LU2097828631.EUR","09988","LU0029875118.USD","BK1574","LU0823038988.USD","BK1503","BK1575","LU0370786039.SGD","LU0149534421.HKD","IE0034224299.USD","LU0828238088.HKD","HK0000306701.USD","SGXZ31699556.SGD","LU0205439572.USD","LU0384037296.USD","LU0287142896.SGD","LU1807302812.USD","BK1580","SG9999000459.SGD","LU1102505929.USD","BK1614","LU1725190679.HKD","SG9999007991.SGD","BK1565","SGXZ62798434.SGD","BK1586","LU0348723411.USD","LU2087589342.USD","LU0819121731.USD","LU2237443895.HKD","KSTmain","SG9999012728.SGD","LU2357305700.SGD","SG9999015978.USD","LU0502904849.HKD","IE00B3M56506.USD","BK1583","LU0683595622.HKD","BK1615","BK1231","BK1224","BK1591","LU1655091459.SGD","LU1196710351.USD","LU0315178854.USD","BK1240","LU0791591158.USD","LU0823039010.USD","LU0572939691.SGD","BK1241","LU1166156734.SGD","LU0918141705.HKD","LU1813983027.USD","02255","LU0589944569.HKD","LU1323998911.USD","LU1880398554.USD","02555","HBBD.SI","LU0211331839.USD","LU0211977185.USD","LU0501845795.SGD","LU1504937902.USD","LU0605514214.HKD","HTCD.SI","03143","SG9999014898.SGD","SG9999004220.SGD","LU0417516902.SGD","SG9999002828.SGD","LU2045819591.USD","02169","LU0029874905.USD","01860","02628","BK1536","LU0130518102.USD","IE00B0169N27.USD","LU0862451753.SGD","LU1522347837.USD","SG9999000418.SGD","BK1095","LU1718418525.SGD","03690","LU0345769128.USD","IE0008368304.USD","SG9999012744.USD","LU0192582467.USD","LU0898667661.SGD","LU2778985437.USD","LU0228367735.SGD","LU0175139822.USD","IE0031814852.USD","LU0611395673.USD","LU2008162690.USD","LU0196878994.USD","LU0128522744.USD","LU1196710195.USD","LU0823413587.USD","IE00B543WZ88.USD","LU0261950983.USD","LU0132412106.USD","LU0648948544.HKD","LU0048580855.USD","SG9999002562.SGD","LU0516423091.SGD","LU0543330483.HKD","LU1251922891.USD","01810","IE00BVYPNP33.GBP","LU1883866441.USD","BK1550","LU1242518931.SGD","SG9999015945.SGD","LU0588545730.USD","LU1044875133.USD","LU0469268626.HKD","LU0856984785.SGD","IE0003795394.USD","BK1227","LU0163747925.USD","BK1501","LU0140636845.USD","LU0345780521.USD","LU1048588211.SGD","LU0266512127.USD","SG9999001689.USD","06690","BK1186","LU0516422440.USD","SG9999013353.USD","LU0441854154.USD","SG9999000327.SGD","IE0032834883.USD","LU0871576103.HKD","BK1544","LU1282649810.SGD","LU1226287792.SGD","LU1497733631.SGD","LU0117841782.USD","LU1733274473.HKD","LU1196710864.SGD","LU2399975544.HKD","SG9999014674.SGD","LU1880398471.USD","LU0228659784.USD","LU1102505762.USD","06818","LU0203347892.USD","LU0865486749.SGD","LU1548497426.USD","LU1642822792.SGD","LU2148510915.USD","03323","LU0675040207.SGD","06969","LU0261947096.USD","LU0456842615.SGD","LU2023250504.SGD","LU0293314216.USD","LU2097829019.USD","IE00B8HQ1Z84.USD","LU0640798160.USD","00107","BK1613","IE00BQXX3F31.USD","LU0890818403.SGD","LU2251237306.USD","IE00B031HY20.USD","LU0862451837.USD","SG9999002950.SGD","LU0634319403.HKD","80883","00173","BK1505","LU1770034418.SGD","LU1235295612.USD","LU0061477393.USD","LU1770036033.HKD","HK0000165453.HKD","BK1518","LU0823413660.USD","LU2039709279.SGD","LU0737861699.HKD","IE00BZ08YT58.USD","IE00B067MR52.USD","BK1152","IE0001KFT4U8.USD","BK1151","LU0320764243.SGD","LU1720051017.SGD","SG9999018857.SGD","SG9999002463.SGD","LU0588545490.SGD","LU0608807946.USD","LU1917777945.USD","LU2097828714.EUR","LU0607220059.USD","LU0577902371.SGD","LU0164872284.USD","LU0117844026.USD","LU0254981946.USD","LU2125910849.SGD","LU1720050803.USD","LU0708995583.HKD","LU0048597586.USD","LU2097828557.USD","LU2106854487.HKD","LU1880383440.USD","BK1506","LU0130103400.USD","LU3063872942.SGD","BK1576","STAN.UK","LU0561508036.HKD","LU1439103000.SGD","LU0289960550.SGD","BK1563","LU1188198961.HKD","LU0509642566.USD","LU2476274720.SGD","LU1481107354.HKD","LU2237443382.USD","LU0831103253.SGD","LU0214875030.USD","BK1567","LU0072462343.USD","LU0630378692.HKD","LU1961090484.USD","SG9999018865.SGD","LU1868837565.USD","BK1589","LU0203345920.USD","LU0642271901.SGD","BK1535","LU0345775950.USD","LU0588546209.SGD","LU0823041008.USD","LU0463099449.HKD","LU0702159343.USD","BK1572","LU0828237510.HKD","LU0149721374.USD","LU0348766576.USD","BK1582","09926","IE00BF5LJ272.USD","LU1810669033.SGD","LU1629966141.USD","HK0000252152.HKD","LU0143863198.USD","LU0106259558.USD","LU0762541174.USD","LU1048484197.HKD","IE00BZ08YR35.GBP","LU2152927971.USD","LU0080751232.USD","IE0032431581.USD","SG9999014914.USD","LU0499858602.USD","LU0417516571.SGD","LU0414403682.SGD","LU1880383366.USD","LU1366334651.USD","02057","LU1023057109.AUD","LU1769817096.USD","LU0477156797.USD","LU0348816934.USD","LU0266512473.USD","BK1592","LU0164865239.USD","LU2237443622.USD","LU1733274390.USD","LU0633140560.USD","LU0577902454.USD","SGXZ51526630.SGD","LU1688375341.USD","BK1214","LU0348788117.USD","LU0650527681.SGD","METmain","LU1115378108.SGD","LU2133065610.SGD","LU0307460666.USD","LU1439102457.SGD","LU0348805143.USD","IE00BZ08YS42.EUR","LU0700851271.USD","LU0821914370.USD","LU2097828805.USD","SGXZ99366536.SGD","LU0039217434.USD","LU1868838027.USD","00981","LU0096374516.USD","BK1601","LU1769817179.HKD","BK1236","LU1044874839.SGD","LU0348827113.USD","LU0868486357.SGD","SG9999012710.SGD","LU0702159699.USD","09992","LU2543165471.USD","BK1148","LU0672654166.SGD","BK1142","BK1104","LU0106959298.USD","LU2488822045.USD","LU1048596156.SGD","LU2293587155.HKD","LU2257852520.SGD","LU0197773673.USD","LU0737861772.HKD","BK1541","LU0878004406.USD","LU2279701549.SGD","GB00BDT5M118.USD","BK1161","IE00B97KM107.HKD","LU0348814723.USD","LU0011963245.USD","LU0651946864.USD","00548","LU1282648689.USD","BK1608","LU0823426308.USD","LU2476274308.USD","LU0873338254.USD","LU0828237940.HKD","BK1555","LU0047713382.USD","LU0594300179.USD","LU0499858438.USD","LU0143863784.USD","LU2237443465.HKD","LU2251237488.HKD","LU1064130708.USD","LU2097828474.EUR","LU0516422952.EUR","LU0348783662.USD","SG9999014880.SGD","09606","LU0259732245.USD","LU0329678170.USD","LU0877626530.USD","LU0786609619.USD","IE00BYV24P56.USD","LU1956131251.USD","HK0000252160.HKD","LU0264606111.USD","LU1974910355.USD","LU2247934214.USD","LU0345776255.USD","BK1233","BK1526","89988","LU0326948709.USD","LU0396098781.USD","LU0210527791.USD","BK1609","LU1868837722.USD","SG9999006514.SGD","LU0210533765.USD","IE0008368742.USD","LU0327786744.USD","HK0000500386.USD","LU0593848301.USD","LU0577902538.SGD","LU0762542818.HKD","LU0823397285.USD","LU0456827905.SGD","LU1226288170.HKD","01361","LU0431992006.USD","LU1951186391.HKD","BK1141","SG9999001903.USD"],"gpt_icon":1},{"id":"1185470634","title":"CISI FIN Initiates Coverage on DUALITYBIO-B (09606) with \"Overweight\" Rating, Highlights Leadership in Next-Gen ADC Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=1185470634","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185470634?lang=en_us&edition=fundamental","pubTime":"2025-11-28 09:24","pubTimestamp":1764293061,"startTime":"0","endTime":"0","summary":"CISI FIN released a research report initiating coverage on DUALITYBIO-B (09606) with an \"Overweight\" rating. The company focuses on the ADC (antibody-drug conjugate) field, leveraging collaborations...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000500386.USD","LU2543165471.USD","09606","BK1147","06058","HK0000252160.HKD","BK4231","ADC","BK1161","BK1564","HK0000252152.HKD","BK4080"],"gpt_icon":0},{"id":"1190899235","title":"HK Pharma Shares Gained. CSPC Pharma Up 7%; 3SBio Up 6%; Remegen Up 4%; Sino Biopharm, Junshi Bio And Hengrui Pharma Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1190899235","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190899235?lang=en_us&edition=fundamental","pubTime":"2025-11-26 09:43","pubTimestamp":1764121396,"startTime":"0","endTime":"0","summary":"HK Pharma Shares Gained. CSPC Pharma Up 7%; 3SBio Up 6%; Remegen Up 4%; Sino Biopharm, Junshi Bio And Hengrui Pharma Up 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"cdafad46000135333541ff3f84174d8f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759","09688","06606","02268","02137","01530","03347","09606","01093","02359","06978","02269","01672","09995","09966"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":71,"code":"91000000","status":"200"}]}}